Vicinity Centres reported FY26 results with statutory net profit after tax up 38.5% from FY25 to $1,391.2 million. Funds from operations (FFO) rose 3.9% to $700.1 million, while comparable net property income increased 4.2%. The group lifted its annual distribution 3.3% to 12.40 cents per security, with a payout ratio of 95.5% of AFFO. Net tangible assets rose 7.7% to $2.59 per security.

Strategy shares closed down 5.28% on Aug. 18 at $92.52 after hitting an intraday low of $92.45. The company holds a $4.8 billion USD reserve, but investors have focused on its pause in Bitcoin purchases. This week, Strategy raised $333.7 million through a stock issuance.

Zip Co reported record FY26 results, with cash EBTDA of $268.9 million up 57.9% year on year. Total revenue rose 24.7% to $1,336.1 million, while net profit after tax increased 45.7% to $116.4 million. Operating margin expanded to 20.0% from 15.8%, and total transaction volume grew 27.2% to $16.7 billion. In the US, transaction volume and revenue rose more than 42% in local currency, and the company expects US transaction volume to grow by more than 30% next year.

Telix Pharmaceuticals reported half-year revenue up 22% year on year to US$477 million, tracking to the upper end of its FY26 guidance. Adjusted EBITDA surged 146% to US$52 million, while gross margin improved to 55% and the Precision Medicine segment margin reached 65%. Profit after tax was US$38 million, including a US$40 million payment from Regeneron, and operating cash flow was positive at US$23 million. The company ended the period with a cash balance of US$252 million.

Australia’s luxury car retailer Autosports Group reported record FY26 revenue of A$3.19 billion, up 11.9% year on year, and normalised profit before tax of A$53.5 million, up 11.1%. New vehicle orders rose 20% from a year earlier, while its order bank has jumped 290% since 30 June 2025. The company said demand for electric vehicles is running well ahead of available stock, contributing to shortages at the end of the quarter. Gross profit climbed 15% to A$589.7 million and the gross margin held steady at 18.5%.

Ascentage Pharma reported unaudited results for the first half of 2026, with revenue up 29% year over year to US$44.5 million, driven mainly by higher Olverembatinib sales. As of June 30, 2026, Olverembatinib had been added to formularies at 879 DTP pharmacies and hospitals. Hospital coverage rose 34% year over year to 394 hospitals.

APA Group reported FY26 results with underlying EBITDA up 8.3% year on year to $2,183 million, beating the midpoint of its guidance. Free cash flow rose 3.2% to $1,118 million, while statutory net profit after tax jumped 81.4% to $234 million. The company lifted its FY26 distribution 1.8% to 58.0 cents per security, marking a 22nd consecutive annual increase.

Cotton futures surged across the board on Wednesday, with front-month contracts up 243 to 294 points and deferred months gaining 53 to 110 points. Crude oil rose $1.90 while the U.S. dollar index fell 0.809. NOAA forecasts show dryness persisting over much of Texas and parts of the Delta over the next week. The Cotlook A Index increased 70 points on August 18 to 96.00 cents, while ICE certified stocks slipped to 70,643 bales and the Adjusted World Price was raised 190 points last week.